5 results match your criteria: "Ascension St Vincent Heart Center of Indiana[Affiliation]"
Timing and Outcomes of PCI in Conjunction With TAVR With Balloon-Expandable Valves.
JACC Cardiovasc Interv
January 2025
Ascension St Vincent Heart Center of Indiana, Indianapolis, Indiana, USA.
Background: The optimal timing for percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve replacement (TAVR) is debatable.
Objectives: The aim of this study was to compare outcomes based on the timing of PCI in stable coronary artery disease patients undergoing TAVR.
Methods: Leveraging the STS/ACC TVT Registry and Medicare Linkage, we analyzed patients with stable coronary artery disease undergoing PCI and TAVR between 2015 and 2023 using the SAPIEN 3 balloon-expandable valve platform.
Optimizing Health Care Resource Allocation, Workforce "Right-Sizing," and Stakeholder Collaboration.
J Soc Cardiovasc Angiogr Interv
December 2024
Cordis, Miami Lakes, Florida.
Left Atrial to Coronary Sinus Shunting for Treatment of Symptomatic Heart Failure.
JACC Cardiovasc Interv
June 2023
Lankenau Heart Institute, Wynnewood, Pennsylvania, USA. Electronic address:
Background: Heart failure (HF) is associated with both mortality and a significant decline in health status. Interatrial shunting is increasingly being investigated as a novel therapeutic option.
Objectives: The ALT FLOW Early Feasibility Study was designed to evaluate the safety of the Edwards left atrial to coronary sinus APTURE Transcatheter Shunt System in patients with symptomatic HF.
Disparities in Utilization of Advanced Structural Heart Cardiovascular Therapies.
J Soc Cardiovasc Angiogr Interv
January 2023
Boston Scientific, Maple Grove, Minnesota.
Re-instituting a live cardiology meeting without symptomatic COVID-19 transmission.
Catheter Cardiovasc Interv
August 2021
Henry Ford Health System, Detroit, Michigan, USA.